Sign In
Buy ABCM
$23.99
+0 (+0%)
At Close: Mar 04, 2024
CAMBRIDGE, England & LOS ANGELES--(BUSINESS WIRE)-- #Biotech--Molecular Instruments® and Abcam partner to announce plug-and-play HCR™ HiFi Encoder compatibility with Abcam's primaries.
Metabolism Assays Market Driven by Increase in Prevalence of Metabolic Disorders Metabolism Assays Market Driven by Increase in Prevalence of Metabolic Disorders
Danaher completes $5.7 billion acquisition of Abcam
08:14am, Wednesday, 06'th Dec 2023
Medical tools supplier Danaher said on Wednesday it has completed the $5.7 billion acquisition of Abcam , overcoming the initial opposition from the founder of the protein consumables maker.
Danaher Completes Acquisition of Abcam
07:30am, Wednesday, 06'th Dec 2023
WASHINGTON , Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for
Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales
04:01pm, Monday, 04'th Dec 2023
CAMBRIDGE, England & WALTHAM, Mass.--(BUSINESS WIRE)--Abcam plc (Nasdaq: ABCM) (‘Abcam', the ‘Group' or the ‘Company'), a global leader in the supply of life science research tools, entered into
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
07:00am, Wednesday, 01'st Nov 2023
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign CAMBRIDGE, England, 1 November 2023 - Jonathan Milner, the founder and one of the largest investors in Abcam plc
Jonathan Milner Issues Statement Responding to the Glass Lewis Report
02:00am, Monday, 23'rd Oct 2023
Jonathan Milner Issues Statement Responding to the Glass Lewis Report Welcomes the Glass Lewis report's observations on the disproportionate rewards for Abcam's Executive Directors and on the identifi
Jonathan Milner Issues Statement Responding to ISS Report
01:12pm, Monday, 16'th Oct 2023
Jonathan Milner Issues Statement Responding to ISS Report Urges shareholders to disregard the ISS report and continue to Vote AGAINST the current proposed acquisition of Abcam by Danaher CAMBRIDGE, En
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company
Exlusive: Why Abcam founder believes Danaher's acquisition offer falls short
08:46am, Monday, 16'th Oct 2023
In an exclusive interview with Thomas Warner (TW) of Proactive London, Dr Jonathan Milner (JM), the founder of life sciences company Abcam PLC (NASDAQ:ABCM), discusses why he believes the $24 per shar
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Abcam plc (N
Jonathan Milner issues Open Letter to shareholders of Abcam plc
07:00am, Tuesday, 10'th Oct 2023
Urges shareholders to question the scheme circular, the unacceptable Offer price and continue to Vote AGAINST the current proposed acquisition of Abcam by Danaher Corporation
GMED or ABCM: Which Is the Better Value Stock Right Now?
12:47pm, Thursday, 05'th Oct 2023
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Abcam PLC Sponsored ADR (ABCM). But which of these two stocks offers value inves
Jonathan Milner issues Open Letter to shareholders of Abcam plc
02:00am, Thursday, 28'th Sep 2023
Jonathan Milner issues Open Letter to shareholders of Abcam plc U rges shareholders to Vote AGAINST the proposed acquisition of Abcam by Danaher Corporation CAMBRIDGE, England, 2 8 September 2023 –
Abcam plc Statement on Dr. Jonathan Milner's Announcement
06:59pm, Thursday, 14'th Sep 2023
CAMBRIDGE, England & WALTHAM, Mass.--(BUSINESS WIRE)--Abcam plc (Nasdaq: ABCM) (“Abcam” or the “Company”), notes today's announcement by Dr. Jonathan Milner. The Company considers it surprisin
